Learn More
Medchemexpress LLC MRS 2211 sodium hydrate | 1197030-56-0 | MFCD09038558 | 97.9% | 470.69 g/mol | C14H13ClN4NaO9P | 5 MG

Supplier: Medchemexpress LLC HY1379555MG
MRS 2211 sodium hydrate is the sodium salt hydrate form of a selective competitive P2Y13 receptor antagonist supplied for research use. It is provided as a brown to reddish-brown solid with reported purity of 97.9%, intended for in vitro pharmacology and biochemical studies of purinergic signaling.
- Selective P2Y13 receptor antagonism (pIC50 ≈ 5.97).
- High reported purity for reliable experimental results.
- Solid form suitable for dissolution and formulation in common solvents.
- Available in small quantities for exploratory and pilot studies.
- Recommended sealed, cold storage to minimize degradation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.